Search Result "Ubrogepant"
Identification, Isolation, Structure Characterization, and Chromatographic Separation of a New Highly Analogous Impurity of the Ubrogepant
Journal: Current Analytical Chemistry
Volume: 21 Issue: 0 Year: 2025 Page: 1-20
Author(s): Nagavardhana Reddy Vanga
Safety and Efficacy of Calcitonin Gene-related Peptide ReceptorAntagonists and Selective Serotonin Receptor Agonist in the Managementof Migraine: A Systematic Review and Meta-analysis
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 23 Issue: 12 Year: 2024 Page: 1474-1487
Author(s): Rakesh Kumar Ponnada
Progress in Analgesic Development: How to Assess its Real Merits?
Journal: Current Reviews in Clinical and Experimental Pharmacology
Volume: 17 Issue: 2 Year: 2022 Page: 90-93
Author(s):
Major Targets Involved in Clinical Management of Migraine
Journal: Current Neurovascular Research
Volume: 20 Issue: 3 Year: 2023 Page: 296-313
Author(s):
New Therapeutic Options for Migraine
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 25 Year: 2023 Page: 1964-1966
Author(s): Maria Adele Giamberardino
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 33 Year: 2017 Page: 3649-3665
Author(s): Melinda Lukacs,Janos Tajti,Ferenc Fulop,Jozsef Toldi,Lars Edvinsson,Laszlo Vecsei
Global Epidemiology, Clinical Features, Diagnosis and Current TherapeuticNovelties in Migraine Therapy and their Prevention: A Narrative Review
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3295-3311
Author(s):
Advances in Migraine Treatment: A Comprehensive Clinical Review
Journal: Current Protein & Peptide Science
Volume: 26 Issue: 6 Year: 2025 Page: 422-435
Author(s):
Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Journal: Current Drug Targets
Volume: 20 Issue: 5 Year: 2019 Page: 522-539
Author(s): Surovi Saikia,Manobjyoti Bordoloi,Rajeev Sarmah
Safety Profile of Statins for Post-Marketing Adverse Cardiovascular Events: A Real-World Pharmacovigilance Analysis
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 25 Issue: 0 Year: 2025 Page: 1-11
Author(s):